335 related articles for article (PubMed ID: 27748895)
1. Comparative molecular analysis of early and late cancer cachexia-induced muscle wasting in mouse models.
Sun R; Zhang S; Lu X; Hu W; Lou N; Zhao Y; Zhou J; Zhang X; Yang H
Oncol Rep; 2016 Dec; 36(6):3291-3302. PubMed ID: 27748895
[TBL] [Abstract][Full Text] [Related]
2. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H
Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162
[TBL] [Abstract][Full Text] [Related]
3. Epigallocatechin-3-gallate effectively attenuates skeletal muscle atrophy caused by cancer cachexia.
Wang H; Lai YJ; Chan YL; Li TL; Wu CJ
Cancer Lett; 2011 Jun; 305(1):40-9. PubMed ID: 21397390
[TBL] [Abstract][Full Text] [Related]
4. Effects of CRF2R agonist on tumor growth and cachexia in mice implanted with Lewis lung carcinoma cells.
Argilés JM; Figueras M; Ametller E; Fuster G; Olivan M; de Oliveira CC; López-Soriano FJ; Isfort RJ; Busquets S
Muscle Nerve; 2008 Feb; 37(2):190-5. PubMed ID: 17912749
[TBL] [Abstract][Full Text] [Related]
5. Morin suppresses cachexia-induced muscle wasting by binding to ribosomal protein S10 in carcinoma cells.
Yoshimura T; Saitoh K; Sun L; Wang Y; Taniyama S; Yamaguchi K; Uchida T; Ohkubo T; Higashitani A; Nikawa T; Tachibana K; Hirasaka K
Biochem Biophys Res Commun; 2018 Dec; 506(4):773-779. PubMed ID: 30389140
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour-bearing mice.
Brown JL; Rosa-Caldwell ME; Lee DE; Blackwell TA; Brown LA; Perry RA; Haynie WS; Hardee JP; Carson JA; Wiggs MP; Washington TA; Greene NP
J Cachexia Sarcopenia Muscle; 2017 Dec; 8(6):926-938. PubMed ID: 28845591
[TBL] [Abstract][Full Text] [Related]
7. Luteolin reduces cancer‑induced skeletal and cardiac muscle atrophy in a Lewis lung cancer mouse model.
Chen T; Li B; Xu Y; Meng S; Wang Y; Jiang Y
Oncol Rep; 2018 Aug; 40(2):1129-1137. PubMed ID: 29845270
[TBL] [Abstract][Full Text] [Related]
8. The Toll-Like Receptor/MyD88/XBP1 Signaling Axis Mediates Skeletal Muscle Wasting during Cancer Cachexia.
Bohnert KR; Goli P; Roy A; Sharma AK; Xiong G; Gallot YS; Kumar A
Mol Cell Biol; 2019 Aug; 39(15):. PubMed ID: 31138662
[TBL] [Abstract][Full Text] [Related]
9. Diet-induced obesity does not exacerbate cachexia in male mice bearing Lewis-lung carcinoma tumors.
Beaudry AG; Law ML; Gilley-Connor KR; Buley H; Dungan CM; Nascimento CMC; Vichaya EG; Wiggs MP
Am J Physiol Regul Integr Comp Physiol; 2024 Mar; 326(3):R254-R265. PubMed ID: 38252513
[TBL] [Abstract][Full Text] [Related]
10. High-intensity eccentric training ameliorates muscle wasting in colon 26 tumor-bearing mice.
Tatebayashi D; Himori K; Yamada R; Ashida Y; Miyazaki M; Yamada T
PLoS One; 2018; 13(6):e0199050. PubMed ID: 29894511
[TBL] [Abstract][Full Text] [Related]
11. Skeletal muscle glycoprotein 130's role in Lewis lung carcinoma-induced cachexia.
Puppa MJ; Gao S; Narsale AA; Carson JA
FASEB J; 2014 Feb; 28(2):998-1009. PubMed ID: 24145720
[TBL] [Abstract][Full Text] [Related]
12. Reduced sucrose nonfermenting AMPK-related kinase (SNARK) activity aggravates cancer-induced skeletal muscle wasting.
Alves CRR; MacDonald TL; Nigro P; Pathak P; Hirshman MF; Goodyear LJ; Lessard SJ
Biomed Pharmacother; 2019 Sep; 117():109197. PubMed ID: 31387190
[TBL] [Abstract][Full Text] [Related]
13. Repeated eccentric contractions positively regulate muscle oxidative metabolism and protein synthesis during cancer cachexia in mice.
Hardee JP; Fix DK; Koh HJ; Wang X; Goldsmith EC; Carson JA
J Appl Physiol (1985); 2020 Jun; 128(6):1666-1676. PubMed ID: 32407241
[TBL] [Abstract][Full Text] [Related]
14. Antibody-directed myostatin inhibition enhances muscle mass and function in tumor-bearing mice.
Murphy KT; Chee A; Gleeson BG; Naim T; Swiderski K; Koopman R; Lynch GS
Am J Physiol Regul Integr Comp Physiol; 2011 Sep; 301(3):R716-26. PubMed ID: 21677277
[TBL] [Abstract][Full Text] [Related]
15. MEF2c-Dependent Downregulation of Myocilin Mediates Cancer-Induced Muscle Wasting and Associates with Cachexia in Patients with Cancer.
Judge SM; Deyhle MR; Neyroud D; Nosacka RL; D'Lugos AC; Cameron ME; Vohra RS; Smuder AJ; Roberts BM; Callaway CS; Underwood PW; Chrzanowski SM; Batra A; Murphy ME; Heaven JD; Walter GA; Trevino JG; Judge AR
Cancer Res; 2020 May; 80(9):1861-1874. PubMed ID: 32132110
[TBL] [Abstract][Full Text] [Related]
16. Effect of c-ski overexpression on the development of cachexia in mice bearing the Lewis lung carcinoma.
Carbó N; Costelli P; Busquets S; López-Soriano J; López-Soriano FJ; Baccino FM; Argilés JM
Int J Mol Med; 2004 Oct; 14(4):719-23. PubMed ID: 15375607
[TBL] [Abstract][Full Text] [Related]
17. Cancer-Induced Muscle Wasting Requires p38β MAPK Activation of p300.
Sin TK; Zhang G; Zhang Z; Zhu JZ; Zuo Y; Frost JA; Li M; Li YP
Cancer Res; 2021 Feb; 81(4):885-897. PubMed ID: 33355181
[TBL] [Abstract][Full Text] [Related]
18. Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse.
Aulino P; Berardi E; Cardillo VM; Rizzuto E; Perniconi B; Ramina C; Padula F; Spugnini EP; Baldi A; Faiola F; Adamo S; Coletti D
BMC Cancer; 2010 Jul; 10():363. PubMed ID: 20615237
[TBL] [Abstract][Full Text] [Related]
19. Anticachectic effects of formoterol: a drug for potential treatment of muscle wasting.
Busquets S; Figueras MT; Fuster G; Almendro V; Moore-Carrasco R; Ametller E; Argilés JM; López-Soriano FJ
Cancer Res; 2004 Sep; 64(18):6725-31. PubMed ID: 15374990
[TBL] [Abstract][Full Text] [Related]
20. Combined treatment of carfilzomib and z-VAD-fmk inhibits skeletal proteolysis and apoptosis and ameliorates cancer cachexia.
Wang Q; Li C; Peng X; Kang Q; Deng D; Zhang L; Zheng Y; Wang C; Qiao Z; Guo D; You S; Tang H
Med Oncol; 2015 Apr; 32(4):100. PubMed ID: 25737433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
